Speak directly to the analyst to clarify any post sales queries you may have.
The structural heart devices market is undergoing a fundamental evolution as healthcare systems seek scalable, minimally invasive solutions to address complex cardiovascular disorders. This transformation is being shaped by technological advances, broader patient eligibility, and changing procurement priorities, offering decision-makers both strategic opportunities and operational challenges.
Market Snapshot: Structural Heart Devices Market Overview
The Structural Heart Devices Market grew from USD 21.06 billion in 2024 to USD 23.01 billion in 2025. It is expected to continue growing at a CAGR of 9.60%, reaching USD 36.51 billion by 2030.
Scope & Segmentation
- Product Types: Accessory devices (including delivery systems, guidewires, introducer sheaths), annuloplasty rings, heart valve devices (mechanical, tissue, transcatheter), occluders and closure devices (atrial septal defect, left atrial appendage, patent foramen ovale, ventricular septal defect).
- Procedure Types: Minimally invasive surgery and open-heart surgery, each catering to specific anatomical and clinical requirements.
- Material Types: Metallic alloys, polymer materials, tissue materials supporting structural integrity, flexibility, and biological integration.
- End Users: Ambulatory surgical centers, hospitals, and specialty cardiac centers, each driving adoption of advanced therapies and care pathways.
- Applications: Surgical aortic valve replacement, transcatheter aortic valve replacement, transcatheter mitral valve repair addressing diverse patient needs.
- Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major economies such as United Kingdom, Germany, France, plus emerging regions), and Asia-Pacific (including markets like China, India, Japan, Australia, South Korea, and others).
- Company Coverage: Abbott Laboratories, AMETEK.Inc., Artivion, BIOTRONIK, Boston Scientific, Braile Biomédica, Braun Medical, Cardinal Health, Direct Flow Medical, Edwards Lifesciences, JenaValve Technology, Johnson & Johnson, Lepu Medical Technology, Livanova, Medtronic, Meril Life Sciences, Micro Interventional Devices, MicroPort Scientific, Relisys Medical Devices, TE Connectivity, Teleflex, Terumo, TTK Healthcare Limited.
Key Takeaways for Strategic Decision-Makers
- Minimally invasive procedures are broadening eligibility, lowering perioperative risks, and optimizing operational efficiency for providers.
- Integration of digital health and machine learning is redefining pre-procedural risk assessment, patient selection, and long-term device monitoring, facilitating data-driven care.
- Investment in adaptive manufacturing and local supply chain capabilities is increasing to mitigate exposure to international trade impacts and ensure continued product availability.
- Established companies are leveraging acquisitions and R&D partnerships to diversify portfolios and accelerate product cycles, while newcomers differentiate with next-generation materials and customized implants.
- Regional adoption trends are shaped by funding models, clinical infrastructure, and regulatory climate—Asia-Pacific’s emphasis on in-region manufacturing and Europe’s value-based procurement being notable examples.
- Sustained leadership hinges on ecosystem collaboration, regulatory agility, and investment in emerging therapeutic approaches.
Tariff Impact
The 2025 introduction of U.S. tariffs on key imported device components is prompting manufacturers to re-evaluate sourcing strategies, balancing between domestic production and diversified supplier networks. This shift is influencing cost structures, procurement models, and commercial agreements across the market. Providers are responding by seeking greater pricing transparency and bundled payment arrangements to counteract potential price increases, while manufacturers are focusing on process efficiency and resilient logistics partnerships.
Robust Methodology & Data Sources
This report is underpinned by primary interviews with experienced clinicians, procurement leaders, and regulatory experts, validated by a rigorous review of scientific literature, clinical registries, patent filings, and company data. Advanced analytics guide the triangulation of qualitative and quantitative signals, while all findings undergo independent expert review to ensure strategic relevance and data integrity.
Why This Report Matters for Senior Leaders
- Enables data-backed planning and execution by providing actionable insights into emerging clinical demands and technology strategies.
- Supports risk mitigation and supply chain resilience initiatives through detailed analysis of policy impacts and procurement best practices.
- Guides portfolio optimization and partnership decisions with a clear framing of competitive and regional market dynamics.
Conclusion
As the structural heart devices sector advances, adaptability, digital intelligence, and cross-sector collaboration are vital for sustainable success. This report delivers the clarity and context needed to inform growth strategies, investment decisions, and long-term leadership in a dynamic global market.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3.2. In-depth analysis of consumer preferences product standardization impact competitive dynamics and regulatory variations across regions
3.3. Evaluation of market maturation intellectual property landscape and formulation of strategic commercialization approaches
3.4. Forward-looking market outlook emerging technological trends and identification of future growth opportunities
4.1.1. Comprehensive Scope and Definition of the Structural Heart Devices Market with Key Growth Drivers and Innovation Opportunities
4.1.2. In-depth Geographic Overview of the Structural Heart Devices Market Addressing Regional Trade Dynamics and Cultural Influences
4.1.3. Detailed Analysis of Recent Developments Including Patents, Innovations, and Regulatory Trends Impacting the Structural Heart Devices Market
4.2. Market Sizing & Forecasting
5.1.1. Comprehensive definition and contextual exploration of the expansion of remote patient monitoring systems linked to structural heart devices
5.1.2. In-depth analysis of the market transformation and opportunity unlocking through remote patient monitoring linked to structural heart devices
5.1.3. Future outlook, long-term implications, and strategic recommendations for stakeholders in the remote patient monitoring expansion linked to structural heart devices
5.2. Growing investments in biodegradable materials for safer structural heart implants
5.2.1. Growing investments in biodegradable materials for structural heart implants with safety and innovation focus
5.2.2. Market transformation due to biodegradable materials enabling innovative and safer structural heart implants
5.2.3. Future outlook and strategic implications of biodegradable materials in structural heart device innovation
5.3. Advancements in minimally invasive structural heart device technologies enhancing patient outcomes
5.3.1. Comprehensive definition and contextual background of advancements in minimally invasive structural heart device technologies enhancing patient outcomes
5.3.2. In-depth analysis on transformative market impact and opportunity creation from advancements in minimally invasive structural heart device technologies
5.3.3. Future projections, strategic recommendations, and potential risks associated with advancements in minimally invasive structural heart devices
5.4. Rising focus on patient-specific customization in structural heart device design and delivery
5.4.1. Trend Definition and Context: Understanding patient-specific customization in structural heart devices
5.4.2. Market Impact: How patient-specific customization is reshaping the structural heart device landscape
5.4.3. Future Outlook and Implications: Long-term trajectory and strategic recommendations for customization in structural heart devices
5.5. Collaborations among tech companies and medtech firms accelerating device innovation
5.5.1. In-depth definition of collaborations between tech and medtech firms accelerating innovation in structural heart devices
5.5.2. Comprehensive analysis of how collaborations reshape the structural heart devices market landscape by driving innovation and opening new opportunities
5.5.3. Future outlook on the deepening collaborations and their long-term implications in the structural heart devices market
5.6. Increasing shifts in regulatory frameworks influencing faster approvals of novel heart devices
5.6.1. Trend Definition and Context: Understanding shifts in regulatory frameworks accelerating approvals of novel heart devices
5.6.2. Market Impact of Accelerated Regulatory Approvals on Innovation and Business Opportunities in Structural Heart Devices
5.6.3. Future Outlook and Strategic Implications of Accelerated Regulatory Approvals in Structural Heart Devices Market
5.7. Development of real-time imaging technologies aiding precise structural heart device placement
5.7.1. Trend Definition & Context: Development and significance of real-time imaging technologies in structural heart device placement
5.7.2. Market Impact: How real-time imaging technologies are transforming the structural heart devices market landscape
5.7.3. Future Outlook & Implications: Long-term trajectory and recommendations for stakeholders in structural heart device markets
5.8. Expansion of structural heart device applications in treating congenital heart defects
5.8.1. Trend Definition and Context Explaining the Expansion of Structural Heart Device Applications in Treating Congenital Heart Defects
5.8.2. How the Expansion of Structural Heart Device Applications is Transforming Market Dynamics and Creating New Business Opportunities
5.8.3. Future Trajectory and Strategic Implications of Expanding Structural Heart Device Uses in Congenital Heart Defect Treatment
5.9. Rising prevalence of cardiovascular diseases increasing demand for innovative heart devices
5.9.1. Definition and Context of the Rising Prevalence of Cardiovascular Diseases in Relation to Structural Heart Devices
5.9.2. Impact on Market Dynamics and Opportunities Due to Increasing Cardiovascular Disease Burden
5.9.3. Future Trajectory and Strategic Implications of Cardiovascular Disease Trends in Structural Heart Device Markets
5.10. Growth of transcatheter valve therapies fueling significant market expansion
5.10.1. Comprehensive definition and contextual understanding of transcatheter valve therapies growth as a market trend
5.10.2. Market transformation and opportunity creation driven by the rise of transcatheter valve therapies
5.10.3. Future projections and strategic implications of ongoing growth in transcatheter valve therapies
6.1.1. Assessing barriers to entry that restrict new competitors in the structural heart devices market
6.1.2. Evaluating the influence of alternative therapies and technologies as substitute threats in the market
6.1.3. Analyzing supplier influence based on component specialization and supply relationship dynamics
6.1.4. Examining how healthcare providers' purchasing decisions shape market pricing and stability
6.1.5. Understanding the intensity of competition and innovation-driven rivalry among key market players
6.2. PESTLE Analysis
6.2.1. Political factors shaping regulatory landscapes and government healthcare policies impacting the structural heart devices market
6.2.2. Economic factors influencing healthcare spending and patient affordability in the structural heart devices market
6.2.3. Social trends related to aging populations and shifting patient attitudes influencing demand for structural heart devices
6.2.4. Technological innovations in minimally invasive procedures and AI-enabled device advancements transforming the structural heart devices market
6.2.5. Legal regulations on device safety, data privacy, and intellectual property shaping the structural heart devices market
6.2.6. Environmental pressures on sustainable production and supply chain resilience in the structural heart devices market
7.2. Discussion on the historical background and economic rationale of U.S. tariff policies from 2018 to 2025 targeting developed and developing countries
7.3. Analysis of the direct inflationary effects of recent U.S. tariff implementations on the global economy with supporting data and statistics
7.4. Examination of reciprocal tariffs and trade wars between the U.S. and its partners in Americas, EMEA, and Asia-Pacific including geopolitical implications
7.5. Evaluation of economic and political impact of U.S. tariffs on major trading partners including both immediate and long-term effects
7.6. Identification of long-term structural changes in the U.S. economy driven by tariff policies including supply chain shifts and consumer impact
7.7. Suggestions for policy responses and mitigation strategies to reduce negative impacts of tariffs on the U.S. economy and trading partners
8.2. Accessory Devices
8.2.1. Delivery Systems
8.2.2. Guidewires
8.2.3. Introducer Sheaths
8.3. Annuloplasty Rings
8.4. Heart Valve Devices
8.4.1. Mechanical Heart Valves
8.4.2. Tissue Heart Valves
8.4.3. Transcatheter Heart Valves
8.5. Occluders & Closure Devices
8.5.1. Atrial Septal Defect Occluders
8.5.2. Left Atrial Appendage Closure Devices
8.5.3. Patent Foramen Ovale Occluders
8.5.4. Ventricular Septal Defect Occluders
9.2. Minimally Invasive Surgery
9.3. Open-Heart Surgery
10.2. Metallic Alloys
10.3. Polymer Materials
10.4. Tissue Materials
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Cardiac Centers
12.2. Surgical Aortic Valve Replacement
12.3. Transcatheter Aortic Valve Replacement
12.4. Transcatheter Mitral Valve Repair
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.1.1. In-depth Examination of Abbott's Rising Structural Heart Devices and Their Market Differentiators
16.3.1.2. Comprehensive Risk Analysis and Strategic Recommendations for Sustained Growth in Abbott's Portfolio
16.3.2. AMETEK.Inc.
16.3.2.1. Introduction to AMETEK, Inc.'s Current Position and Strategic Role in the Market with Core Strengths and Global Reach
16.3.2.2. Detailed Analysis of AMETEK, Inc.'s Flagship Products and Services Addressing Structural Heart Device Needs with Unique Selling Propositions
16.3.2.3. Comprehensive Risk and Vulnerability Assessment with Strategic Recommendations to Enhance AMETEK, Inc.'s Growth and Market Position
16.3.3. Artivion, Inc.
16.3.3.1. Comprehensive Analysis of Artivion's Flagship Structural Heart Devices and Market Alignment with Consumer Needs
16.3.3.2. Thorough Risk Evaluation and Strategic Approaches for Enhancing Artivion's Market Position and Product Portfolio
16.3.4. BIOTRONIK SE & Co. KG
16.3.4.1. Detailed analysis of BIOTRONIK's innovative flagship products and services catering to the structural heart device target market
16.3.4.2. Comprehensive risk and vulnerability assessment with actionable strategies to enhance BIOTRONIK's market position and product portfolio
16.3.5. Boston Scientific Corporation
16.3.5.1. Introduction to the company’s strategic positioning and core strengths in structural heart device market
16.3.5.2. Comprehensive analysis of flagship structural heart products addressing targeted patient needs
16.3.5.3. Strategic risk analysis and actionable growth initiatives for future market leadership
16.3.6. Braile Biomédica Indústria, Comércio e Representações Ltda.
16.3.6.1. In-depth analysis of Braile Biomédica’s flagship structural heart devices and their market alignment
16.3.6.2. Comprehensive evaluation of risks and vulnerabilities affecting Braile Biomédica’s growth and strategies for market strengthening
16.3.7. Braun Medical, Inc.
16.3.7.1. Comprehensive introduction to Braun Medical's strategic positioning and market presence in structural heart devices
16.3.7.2. Detailed analysis of Braun Medical's flagship products addressing market needs and competitive advantages
16.3.7.3. In-depth risk and vulnerability assessment alongside strategic growth and diversification opportunities for Braun Medical
16.3.8. Cardinal Health, Inc.
16.3.8.1. In-depth analysis of Cardinal Health flagship products and services tailored to structural heart devices market
16.3.8.2. Critical risk and vulnerability assessment with strategic initiatives for future-proofing Cardinal Health in structural heart devices sector
16.3.9. Direct Flow Medical, Inc.
16.3.9.1. Comprehensive overview of Direct Flow Medical Inc including its market role strategic position and geographic footprint
16.3.9.2. Detailed analysis of flagship structural heart products including unique features functionalities and market alignment
16.3.9.3. Thorough risk and vulnerability assessment alongside actionable strategic growth recommendations for future market resilience
16.3.10. Edwards Lifesciences Corporation
16.3.10.1. In-depth analysis of Edwards Lifesciences’ flagship products and their alignment with evolving patient and clinical needs
16.3.10.2. Comprehensive risk and vulnerability assessment with strategic recommendations for sustained growth and innovation
16.3.11. JenaValve Technology, Inc.
16.3.11.1. In-depth Analysis of JenaValve Technology’s Flagship Products and Their Market Alignment with Consumer Needs
16.3.12. Johnson & Johnson Services, Inc.
16.3.12.1. In-depth analysis of Johnson & Johnson Services flagships in structural heart devices revealing features and market alignment
16.3.12.2. Comprehensive risk assessment with strategic growth initiatives for Johnson & Johnson Services in structural heart devices
16.3.13. Lepu Medical Technology (Beijing) Co., Ltd.
16.3.13.1. Comprehensive analysis of flagship structural heart devices and their unique market positioning
16.3.13.2. Thorough risk and vulnerability assessment with strategic growth recommendations for Lepu Medical
16.3.14. Livanova PLC
16.3.14.1. In-depth analysis of Livanova PLC's flagship products and services that cater to the target market
16.3.14.2. Comprehensive risk and vulnerability assessment with actionable strategies for Livanova PLC's future growth and market position
16.3.15. Medtronic plc
16.3.15.1. Comprehensive analysis of Medtronic's flagship structural heart devices and their alignment with market needs
16.3.15.2. In-depth risk and vulnerability assessment with strategic initiatives to future-proof Medtronic's market leadership
16.3.16. Meril Life Sciences Pvt. Ltd.
16.3.16.1. Comprehensive analysis of Meril Life Sciences flagship products and services highlighting unique features and market alignment
16.3.16.2. In-depth risk and vulnerability assessment with actionable strategies for Meril Life Sciences to sustain growth and innovation
16.3.17. Micro Interventional Devices, Inc.
16.3.17.1. In-depth analysis of Micro Interventional Devices flagship products and services targeting specialized clinical needs
16.3.17.2. Comprehensive risk and vulnerability assessment with strategic recommendations for future growth and innovation
16.3.18. MicroPort Scientific Corporation's
16.3.18.1. In-depth examination of MicroPort Scientific Corporation's flagship products and their market relevance enhancing patient care
16.3.18.2. Comprehensive risk analysis and actionable strategies to mitigate vulnerabilities while capitalizing on emerging trends in structural heart devices
16.3.19. Relisys Medical Devices Limited.
16.3.19.1. In-depth examination of flagship products and services addressing structural heart device needs
16.3.19.2. Comprehensive risk and vulnerability assessment with strategic growth recommendations for future positioning
16.3.20. TE Connectivity Corporation
16.3.20.1. Detailed analysis of TE Connectivity Corporation's flagship products and services catering to structural heart devices market
16.3.20.2. Comprehensive risk and vulnerability assessment with strategic recommendations for TE Connectivity Corporation in structural heart devices market
16.3.21. Teleflex Incorporated.
16.3.21.1. In-depth overview of Teleflex Incorporated's current market role strategic positioning and core strengths within the medical technology sector
16.3.21.2. Detailed analysis of Teleflex Incorporated's flagship structural heart products services emphasizing unique selling propositions and market impact
16.3.21.3. Comprehensive risk vulnerability assessment with actionable strategies to strengthen Teleflex Incorporated's product portfolio and market position over the upcoming years
16.3.22. Terumo Corporation
16.3.22.1. Identification and Analysis of Terumo Corporations Flagship Products and Services Catering to the Target Market with Unique Selling Propositions
16.3.22.2. Comprehensive Risk and Vulnerability Assessment with Strategic Recommendations for Product Portfolio Enhancement and Market Competitiveness
16.3.23. TTK Healthcare Limited
16.3.23.1. In-depth Analysis of TTK Healthcare Limited Flagship Products and Services with Market Relevance and Competitive Edge
16.3.23.2. Comprehensive Risk and Vulnerability Assessment with Strategic Recommendations for Sustainable Growth and Product Portfolio Enhancement
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
FIGURE 2. STRUCTURAL HEART DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. STRUCTURAL HEART DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STRUCTURAL HEART DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STRUCTURAL HEART DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY METALLIC ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY POLYMER MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SURGICAL AORTIC VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 59. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 61. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 68. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 69. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 108. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 109. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 110. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 116. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 117. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 118. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 132. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 133. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 134. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 140. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 141. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 142. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 172. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 173. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 174. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. DENMARK STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 188. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 189. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 190. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. QATAR STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 197. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 198. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 220. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 221. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 222. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EGYPT STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 229. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 230. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TURKEY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 246. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 252. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 253. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 254. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 277. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 278. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 279. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. CHINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 285. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 286. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 287. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 288. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. INDIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 294. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 295. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. JAPAN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA STRUCTURAL HEART DEVI
Samples
LOADING...
Companies Mentioned
The companies profiled in this Structural Heart Devices market report include:- Abbott Laboratories
- AMETEK.Inc.
- Artivion, Inc.
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Braile Biomédica Indústria, Comércio e Representações Ltda.
- Braun Medical, Inc.
- Cardinal Health, Inc.
- Direct Flow Medical, Inc.
- Edwards Lifesciences Corporation
- JenaValve Technology, Inc.
- Johnson & Johnson Services, Inc.
- Lepu Medical Technology (Beijing) Co., Ltd.
- Livanova PLC
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- Micro Interventional Devices, Inc.
- MicroPort Scientific Corporation's
- Relisys Medical Devices Limited.
- TE Connectivity Corporation
- Teleflex Incorporated.
- Terumo Corporation
- TTK Healthcare Limited
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 193 |
Published | May 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 23.01 Billion |
Forecasted Market Value ( USD | $ 36.51 Billion |
Compound Annual Growth Rate | 9.6% |
Regions Covered | Global |
No. of Companies Mentioned | 24 |